ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
65.43
-0.71 (-1.07%)
Apr 24, 2024, 4:00 PM EDT - Market closed
ANI Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 486.82 | 316.39 | 216.14 | 208.48 | 206.55 | 201.58 | 176.84 | 128.62 | 76.32 | 55.97 | Upgrade
|
| Revenue Growth (YoY) | 53.87% | 46.38% | 3.67% | 0.93% | 2.47% | 13.99% | 37.49% | 68.53% | 36.36% | 86.06% | Upgrade
|
| Cost of Revenue | 181.51 | 138.79 | 100.61 | 87.16 | 63.15 | 73.02 | 79.03 | 48.78 | 12.69 | 11.47 | Upgrade
|
| Gross Profit | 305.3 | 177.6 | 115.53 | 121.32 | 143.39 | 128.55 | 97.81 | 79.84 | 63.63 | 44.5 | Upgrade
|
| Selling, General & Admin | 161.7 | 124.04 | 84.29 | 64.99 | 55.84 | 44.06 | 31.58 | 27.83 | 21.16 | 17.94 | Upgrade
|
| Research & Development | 34.29 | 22.32 | 11.37 | 16 | 19.81 | 15.39 | 9.07 | 2.91 | 2.87 | 2.68 | Upgrade
|
| Other Operating Expenses | 61.08 | 62.09 | 63.5 | 56.84 | 51.62 | 34.29 | 28.78 | 29.1 | 6.86 | 3.72 | Upgrade
|
| Operating Expenses | 257.07 | 208.46 | 159.16 | 137.83 | 127.27 | 93.74 | 69.43 | 59.84 | 30.89 | 24.33 | Upgrade
|
| Operating Income | 48.24 | -30.86 | -43.64 | -16.51 | 16.12 | 34.81 | 28.38 | 20.01 | 32.74 | 20.17 | Upgrade
|
| Interest Expense / Income | 26.94 | 28.05 | 11.92 | 9.45 | 12.97 | 14.76 | 12.04 | 11.33 | 11.01 | 0.79 | Upgrade
|
| Other Expense / Income | 1.43 | 3.76 | 0.5 | - | - | - | - | - | - | - | Upgrade
|
| Pretax Income | 19.87 | -62.67 | -56.06 | -25.96 | 3.16 | 20.05 | 16.35 | 8.68 | 21.73 | 19.38 | Upgrade
|
| Income Tax | 1.09 | -14.77 | -13.46 | -3.41 | -2.94 | 4.56 | 17.43 | 4.74 | 6.36 | -9.37 | Upgrade
|
| Net Income | 18.78 | -47.9 | -42.6 | -22.55 | 6.09 | 15.49 | -1.08 | 3.93 | 15.38 | 28.75 | Upgrade
|
| Preferred Dividends | 1.63 | 1.63 | 0.19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Net Income Common | 17.15 | -49.52 | -42.79 | -22.55 | 6.09 | 15.49 | -1.08 | 3.93 | 15.38 | 28.75 | Upgrade
|
| Net Income Growth | - | - | - | - | -60.67% | - | - | -74.41% | -46.52% | 9450.50% | Upgrade
|
| Shares Outstanding (Basic) | 18 | 16 | 13 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 16 | 13 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | Upgrade
|
| Shares Change | 11.89% | 29.09% | 5.28% | -0.63% | 2.28% | 1.95% | -0.22% | 0.14% | 4.56% | 117.96% | Upgrade
|
| EPS (Basic) | 0.86 | -3.05 | -3.40 | -1.88 | 0.51 | 1.31 | -0.09 | 0.34 | 1.34 | 2.61 | Upgrade
|
| EPS (Diluted) | 0.85 | -3.05 | -3.40 | -1.88 | 0.50 | 1.30 | -0.09 | 0.34 | 1.32 | 2.59 | Upgrade
|
| EPS Growth | - | - | - | - | -61.54% | - | - | -74.24% | -49.03% | - | Upgrade
|
| Free Cash Flow | 110.09 | -39.33 | 3.41 | 9.13 | 39 | 61.33 | 29.05 | 22.91 | -15.42 | -13.72 | Upgrade
|
| Free Cash Flow Per Share | 6.05 | -2.42 | 0.27 | 0.76 | 3.24 | 5.21 | 2.52 | 1.98 | -1.33 | -1.24 | Upgrade
|
| Gross Margin | 62.71% | 56.13% | 53.45% | 58.19% | 69.42% | 63.77% | 55.31% | 62.07% | 83.37% | 79.50% | Upgrade
|
| Operating Margin | 9.91% | -9.75% | -20.19% | -7.92% | 7.81% | 17.27% | 16.05% | 15.55% | 42.90% | 36.03% | Upgrade
|
| Profit Margin | 3.52% | -15.65% | -19.80% | -10.82% | 2.95% | 7.69% | -0.61% | 3.06% | 20.14% | 51.36% | Upgrade
|
| Free Cash Flow Margin | 22.61% | -12.43% | 1.58% | 4.38% | 18.88% | 30.43% | 16.43% | 17.81% | -20.20% | -24.51% | Upgrade
|
| Effective Tax Rate | 5.50% | - | - | - | -93.03% | 22.73% | 106.58% | 54.67% | 29.26% | -48.34% | Upgrade
|
| EBITDA | 107.87 | 25.04 | 3.12 | 28.13 | 60.74 | 68.55 | 56.31 | 42.35 | 39.64 | 24.04 | Upgrade
|
| EBITDA Margin | 22.16% | 7.91% | 1.44% | 13.49% | 29.40% | 34.01% | 31.84% | 32.92% | 51.94% | 42.96% | Upgrade
|
| Depreciation & Amortization | 61.06 | 59.65 | 47.25 | 44.64 | 44.61 | 33.74 | 27.93 | 22.34 | 6.9 | 3.88 | Upgrade
|
| EBIT | 46.81 | -34.61 | -44.14 | -16.51 | 16.12 | 34.81 | 28.38 | 20.01 | 32.74 | 20.17 | Upgrade
|
| EBIT Margin | 9.62% | -10.94% | -20.42% | -7.92% | 7.81% | 17.27% | 16.05% | 15.55% | 42.90% | 36.03% | Upgrade
|